Developer plots sprawling biotech complex near Boston

A developer has blueprinted a sprawling 250-acre biotech complex in the Boston area's thriving life sciences cluster. Patriot Partners says it will negotiate with the town of Burlington for the land and development costs have been estimated in the hundreds of millions of dollars.

The developers do not have any tenants lined up for the laboratory and office space they're planning to build, but the suburbs around Boston have been attracting a large number of developers from Cambridge and other sites. It's also the first big development announced since the Legislature approved a $1 billion program to support the industry.

- reaad the story from the Boston Globe

Suggested Articles

In this week's EuroBiotech Report, Roche's risdiplam clears another phase 3 SMA trial, Merck KGaA spinout raises cash and Korean VCs back PDC*line.

In our EuroBiotech roundup this week, a liver disease biotech raises €11 million, Autolus offers stock and Abivax plans midphase trial. 

Merck KGaA spinout iOnctura has raised a €15 million series A round to support an early-phase solid tumor trial of a PI3Kδ inhibitor.